Trandolapril + Rapamycin Interaction
Moderateinteraction on record
Description
Mammalian Target of Rapamycin (mTOR) Inhibitors Patients taking concomitant mTOR inhibitor (e.g., temsirolimus, sirolimus, everolimus) therapy may be at increased risk for angioedema (see Warnings – Head and Neck Angioedema).
Source: FDA drug label - trandolapril